{"nbformat": 4, "nbformat_minor": 5, "cells": [{"cell_type": "markdown", "metadata": {}, "source": "This notebook will analyze clinical data from EHE patients treated with nab-paclitaxel and ICIs."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "import pandas as pd\n\n# Load patient response data\ndata = pd.read_csv('EHE_patient_data.csv')\n\n# Analyze response rates\nresponse_rates = data['response'].value_counts(normalize=True)\nresponse_rates"}, {"cell_type": "markdown", "metadata": {}, "source": "The analysis will provide insights into the effectiveness of the treatment combinations."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "# Visualize response rates\nimport matplotlib.pyplot as plt\nresponse_rates.plot(kind='bar')\nplt.title('Response Rates to Nab-Paclitaxel and ICIs')\nplt.xlabel('Response')\nplt.ylabel('Proportion')\nplt.show()"}, {"cell_type": "markdown", "metadata": {}, "source": "\n\n\n\n***\n### [**Evolve This Code**](https://biologpt.com/?q=Evolve%20Code%3A%20Analyze%20patient%20response%20data%20to%20nab-paclitaxel%20and%20ICIs%20to%20identify%20potential%20biomarkers%20for%20treatment%20efficacy.%0A%0AInclude%20more%20detailed%20patient%20demographic%20data%20and%20treatment%20history%20to%20enhance%20analysis%20accuracy.%0A%0Anab-paclitaxel%20immune%20checkpoint%20inhibitors%20advanced%20EHE%20disease%20control%0A%0AThis%20notebook%20will%20analyze%20clinical%20data%20from%20EHE%20patients%20treated%20with%20nab-paclitaxel%20and%20ICIs.%0A%0Aimport%20pandas%20as%20pd%0A%0A%23%20Load%20patient%20response%20data%0Adata%20%3D%20pd.read_csv%28%27EHE_patient_data.csv%27%29%0A%0A%23%20Analyze%20response%20rates%0Aresponse_rates%20%3D%20data%5B%27response%27%5D.value_counts%28normalize%3DTrue%29%0Aresponse_rates%0A%0AThe%20analysis%20will%20provide%20insights%20into%20the%20effectiveness%20of%20the%20treatment%20combinations.%0A%0A%23%20Visualize%20response%20rates%0Aimport%20matplotlib.pyplot%20as%20plt%0Aresponse_rates.plot%28kind%3D%27bar%27%29%0Aplt.title%28%27Response%20Rates%20to%20Nab-Paclitaxel%20and%20ICIs%27%29%0Aplt.xlabel%28%27Response%27%29%0Aplt.ylabel%28%27Proportion%27%29%0Aplt.show%28%29%0A%0A)\n***\n\n### [Created with BioloGPT](https://biologpt.com/?q=Does%20combining%20nab-paclitaxel%20with%20immune%20checkpoint%20inhibitors%20improve%20disease%20control%20in%20advanced%20EHE%20patients%3F)\n[![BioloGPT Logo](https://biologpt.com/static/icons/bioinformatics_wizard.png)](https://biologpt.com/)\n***"}], "metadata": {"title": "Analyze patient response data to nab-paclitaxel and ICIs to identify potential biomarkers for treatment efficacy.", "kernelspec": {"display_name": "Python 3", "language": "python", "name": "python3"}, "language_info": {"name": "python", "version": "3.13", "mimetype": "text/x-python", "codemirror_mode": {"name": "ipython", "version": 3}, "file_extension": ".py", "pygments_lexer": "ipython3"}, "author": "BioloGPT", "creation_date": "2025-03-12", "tags": ["nab-paclitaxel immune therapy EHE", "biology", "bioinformatics"]}}